StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JMP Securities Downgrades Achillion Pharmaceuticals (ACHN) to Market Perform Following Acquisition Offer
November 7, 2019 12:40 PM
JMP Securities analyst Liisa Bayko downgraded Achillion Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Downgrades
Next Articles
Achillion Pharma (ACHN) Reports Clearance of Investigational New Drug Application for ACH-5228
November 11, 2019 7:33 AM